PIB CAP

Pneumonia Investigation Bundle to Guide Therapy for Hospitalised Community Acquired Pneumonia

The main aim of the study is to determine whether participants admitted to hospital with community acquired pneumonia can safely receive personalised antibiotic therapy within 36 hours of hospital admission.

 

ECTU PIBCAP logo

Chief Investigator: Prof Adam Hill

Number and location of participating sites / geographical scope (by region/ country): Edinburgh, Nottingham, Newcastle, Birmingham and London.

Funder NIHR HTA

 

Start and End date

Of grant award 01 December 2017 - 31 March 2021

Of recruitment 27 May 2019 - 24 February 2021

 

Status: Closed

 

Protocol document:

 

UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document.

 

Email: PIBCAP@ed.ac.uk

 

Co-sponsor Representative: Dr Fiach O'Mahony, University of Edinburgh & NHS Lothian ACCORD, The Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, Tel: 0131 242 9418, Email: fiach.o'mahony@ed.ac.uk, Website: http://accord.scot/

Chief Investigator: Prof Adam Hill, Respiratory Medicine Consultant, Department of Respiratory Medicine, The Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, Tel: 0131 242 1921, Email: Adam.Hill@ed.ac.uk

Trial Manager: Emma Ward, Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh

Level 2, Nine Edinburgh BioQuarter, 9 Little France Road, Edinburgh

EH16 4UX, Tel: 0131 651 9910, Email: e.ward@ed.ac.uk

 

ECTU involvement: Trial management / Statistics / Health Economics / Database and randomisation

(UKCRC)

This article was published on